4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001193805-24-001131
10% owner bought 70,000 shares at $18.00 ($1,260,000)
- 10% owner acquired 1,725,174 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flynn James E 10% owner | 2024-09-17 | Conversion | +862,587 | 862,587 | I: show line 1 in the form | ||
| Flynn James E 10% owner | 2024-09-17 | Conversion | +862,587 | 862,587 | I: show line 2 in the form | ||
| Flynn James E 10% owner | 2024-09-17 | Purchase | +35,000 | $18.00 | $630,000 | 897,587 | I: show line 3 in the form |
| Flynn James E 10% owner | 2024-09-17 | Purchase | +35,000 | $18.00 | $630,000 | 897,587 | I: show line 4 in the form |
| Open-market purchases · 70,000 sh · avg $18.00 · $1,260,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flynn James E 10% owner | 2024-09-17 | Conversion · Series C Preferred Stock | −7,973,325 | 0 | I: show line 5 in the form | ||
| Flynn James E 10% owner | 2024-09-17 | Conversion · Series C Preferred Stock | −7,973,325 | 0 | I: show line 6 in the form |
Loading xslF345X05/e663893_4-bicara.xml…